Dysregulation, dysfunction, or mutation in SYNE1/Nesprin-1 plays an important role in oral cancer [36], glioblastoma [24], breast cancer [37], ovarian cancer [19] and HCC [38,39], possibly through the regulation of cell proliferation and apoptosis [40]. The gene discussed is SYNE1; the disease is hepatocellular carcinoma.